Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 227 is one of numerous *pseudogenes* related to the 7SK small nuclear RNA gene, which is an essential non-coding RNA with nuclear regulatory functions in eukaryotes[1]. Pseudogenes like RN7SKP227 are dispersed throughout higher eukaryotic genomes and are sequences homologous to functional small RNAs, but they do not encode functional transcripts or proteins[1]. Such pseudogenes typically arise via integration of reverse-transcribed cDNA copies of parental small RNAs, often by self-priming, leading to truncated or otherwise nonfunctional gene copies[1]. The parental gene, 7SK RNA, is a key regulator of transcriptional elongation by RNA polymerase II, but the pseudogene itself has no known biological activity, therapeutic relevance, or established disease association[1]. There is no evidence that this specific pseudogene ("RN7SK pseudogene 227") serves as a receptor, enzyme, transporter, or other druggable target, nor is it implicated in disease, used as a biomarker, or pharmacologically actionable[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 227 (RN7SKP227).